Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress

Hepatocellular carcinoma (HCC) is one of the cancers that seriously threaten human health. Immunotherapy serves as the mainstay of treatment for HCC patients by targeting the programmed cell death protein 1/programmed cell death 1 ligand 1 (PD-1/PD-L1) axis. However, the effectiveness of anti-PD-1/P...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Ziwei Li, Dongyu Duan, Li Li, Dan Peng, Yue Ming, Rui Ni, Yao Liu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2024-06-01
Schriftenreihe:	Frontiers in Pharmacology
Schlagworte:	tumor-associated macrophages (TAMs) hepatocellular carcinoma (HCC) PD-1/PD-L1 T cell immunotherapy
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1382256/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!